We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Portable Quadruplex PCR System Unveiled

By LabMedica International staff writers
Posted on 08 Mar 2018
Print article
Image: The Maverick portable quadruplex PCR system (Photo courtesy of Anitoa Systems).
Image: The Maverick portable quadruplex PCR system (Photo courtesy of Anitoa Systems).
An early-access program for a portable real time quantitative polymerase chain reaction (qPCR) system has been launched. The platform weighs one kilogram and can run quadruplex qPCR on each of four samples simultaneously.

The system combines low-light complementary metal–oxide–semiconductor, or CMOS, biosensors with microfluidics to miniaturize medical devices at a reduced cost. The system is initially targeting the platform toward the research and applied markets, and eventually diagnostics.

The system is called Maverick (Anitoa Systems, Menlo Park, CA) and is an ultra-portable, Bluetooth(R) 2.0 enabled qPCR system that is compatible with standard qPCR assays, with up to 4-channel multiplexing. Target applications are rapid, on-the-site nucleic acid test of infectious diseases; blood screening; food safety and environmental monitoring. Maverick features a 4-channel fluorescence optical system based on Anitoa ULS24 Ultra-low light Bio-imaging chip. With no internal moving parts, Maverick is rugged and requires no calibration to operate.

In terms of the thermal cycler itself, the instrument uses standard Peltier cycling, but Anitoa has adapted techniques from the computing industry to miniaturize its systems. For example, it used technologies to manage heat that are commonly used in handset manufacturing, and heat sink innovations from the personal computing industry. Overall, the system can heat at 5° C per second and cool at 4° C per second, enabling a sub-30-minute test cycle. The Maverick is different from some of the other available systems in that it is real-time PCR, so it is quantitative, and it can be multiplexed with optical channels enabling detection of up to four targets per tube. The company plans for a commercial release of the Maverick in the summer, and is currently supplying beta products as part of its early-access program.

Zhimin Ding, PhD, the CEO of Anitoa Systems, said, “Our system is a direct imaging system, so there is no need for calibration in the field. Subsequent image analysis software quantifies the reaction. In contrast, in systems that use a photodiode to pick up signal, alignment of the diode and tubes needs to be accurate, and re-calibrated if the machine is jolted or shaken. Compared to other systems, the Maverick is lighter and more portable, and, since Anitoa controls the manufacture of its optical components, it can be more cost competitive than a number of other systems. It will cost between USD 3,500 and USD 6,000, depending on the number of optical channels a customer needs in the instrument.” The device was shown at the Molecular Medicine Tri-Conference held February 11-16, 2018, in San Francisco, CA, USA.

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.